Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Madden

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Anaerobe|March 21, 2024
Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infectionGirija Ramakrishnan, Mary K Young, Uma Nayak, et al.
Research Square|April 1, 2024
Early Initiation of Ceftaroline-Based Combination Therapy for Methicillin-resistant Staphylococcus aureus BacteremiaAddison S Hicks, Mackenzie A Dolan, Megan D Shah, et al.
Annals of Clinical Microbiology and Antimicrobials|January 13, 2025
Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremiaAddison S Hicks, Mackenzie A Dolan, Megan D Shah, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
IL-33 protects from recurrent <i>C. difficile</i> infection by restoration of humoral immunityFarha Naz, Nicholas Hagspiel, Mary K Young, et al.
Open Forum Infectious Diseases|February 11, 2022
Binary Toxin Expression by <i>Clostridioides difficile</i> Is Associated With Worse DiseaseMary K Young, Jhansi L Leslie, Gregory R Madden, et al.
Mbio|May 28, 2020
Immune Profiling To Predict Outcome of Clostridioides difficile InfectionMayuresh M Abhyankar, Jennie Z Ma, Kenneth W Scully, et al.
Frontiers in Microbiology|April 29, 2024
<i>Clostridioides difficile</i> infection is associated with differences in transcriptionally active microbial communitiesJeremy R Chen See, Jillian Leister, Justin R Wright, et al.
The Journal of Clinical Investigation|March 6, 2025
IL-33 protects from recurrent C. difficile infection by restoration of humoral immunityFarha Naz, Md Jashim Uddin, Nicholas Hagspiel, et al.
JCI Insight|November 18, 2025
Fecal microbiota transplantation promotes type 2 mucosal immune responses with colonic epithelium proliferation in patients with recurrent Clostridioides difficileG Brett Moreau, Jiayi Tian, Nick R Natale, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profileJeffrey M Sturek, Tania A Thomas, James D Gorham, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Anaerobe|March 21, 2024
Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infectionGirija Ramakrishnan, Mary K Young, Uma Nayak, et al.
Research Square|April 1, 2024
Early Initiation of Ceftaroline-Based Combination Therapy for Methicillin-resistant Staphylococcus aureus BacteremiaAddison S Hicks, Mackenzie A Dolan, Megan D Shah, et al.
Annals of Clinical Microbiology and Antimicrobials|January 13, 2025
Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremiaAddison S Hicks, Mackenzie A Dolan, Megan D Shah, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
IL-33 protects from recurrent <i>C. difficile</i> infection by restoration of humoral immunityFarha Naz, Nicholas Hagspiel, Mary K Young, et al.
Open Forum Infectious Diseases|February 11, 2022
Binary Toxin Expression by <i>Clostridioides difficile</i> Is Associated With Worse DiseaseMary K Young, Jhansi L Leslie, Gregory R Madden, et al.
Mbio|May 28, 2020
Immune Profiling To Predict Outcome of Clostridioides difficile InfectionMayuresh M Abhyankar, Jennie Z Ma, Kenneth W Scully, et al.
Frontiers in Microbiology|April 29, 2024
<i>Clostridioides difficile</i> infection is associated with differences in transcriptionally active microbial communitiesJeremy R Chen See, Jillian Leister, Justin R Wright, et al.
The Journal of Clinical Investigation|March 6, 2025
IL-33 protects from recurrent C. difficile infection by restoration of humoral immunityFarha Naz, Md Jashim Uddin, Nicholas Hagspiel, et al.
JCI Insight|November 18, 2025
Fecal microbiota transplantation promotes type 2 mucosal immune responses with colonic epithelium proliferation in patients with recurrent Clostridioides difficileG Brett Moreau, Jiayi Tian, Nick R Natale, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profileJeffrey M Sturek, Tania A Thomas, James D Gorham, et al.
Pageof 5